These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3278938)

  • 21. Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation.
    Olalla JI; Ortín M; Hermida G; Baro J; Sedano C; Morante C; Zubizarreta A
    Bone Marrow Transplant; 1999 Jan; 23(1):83-5. PubMed ID: 10037055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor.
    Hequet O; Morelon E; Bourgeot JP; Dubois V; Devauchelle B; Dubernard JM; Michallet M
    Bone Marrow Transplant; 2008 Jun; 41(12):1059-61. PubMed ID: 18317458
    [No Abstract]   [Full Text] [Related]  

  • 23. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Allogeneic bone marrow transplantation in a patient with bone marrow aplasia].
    Sauer H; Jehn U; Kolb HJ; Ledderose G; Wilmanns W
    Internist (Berl); 1980 Jul; 21(7):400-5. PubMed ID: 7007282
    [No Abstract]   [Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation in Japan.
    Okamoto S; Asano S; Shibata H; Kodera Y; Masaoka T
    Bone Marrow Transplant; 1994 Jun; 13(6):741-2. PubMed ID: 7920307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cytomegalovirus-infected cells in bone marrow biopsy specimens obtained before allogeneic bone marrow transplantation from donors and recipients.
    Fest T; Angonin R; Mougin C; Deschaseaux M; Lab M; Cahn JY; Herve P
    Transplantation; 1994 Jun; 57(11):1681-3. PubMed ID: 8009607
    [No Abstract]   [Full Text] [Related]  

  • 27. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Children in isolators. Allogeneic bone marrow transplantation. Indications].
    Fischer A
    Soins Pediatr Pueric; 1996 Sep; (172):5-11. PubMed ID: 8949028
    [No Abstract]   [Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation.
    Dicke KA; van Bekkum DW
    Transplant Proc; 1971 Mar; 3(1):666-8. PubMed ID: 4398506
    [No Abstract]   [Full Text] [Related]  

  • 30. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 31. Acetazolamide-induced severe pancytopenia mimicking myelodysplasia relapse following allogeneic bone marrow transplantation.
    Maclean R; O'Callaghan U; Lim SH
    Bone Marrow Transplant; 1998 Feb; 21(3):309-11. PubMed ID: 9489658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamic bone marrow take and lymphohematopoietic chimerism following allogeneic bone marrow transplantation].
    Demidova IA; Savchenko VG
    Ter Arkh; 1995; 67(8):74-80. PubMed ID: 7482347
    [No Abstract]   [Full Text] [Related]  

  • 33. [Allogeneic bone marrow transplantation in adult patients with serious hematological diseases 1985-1992].
    Brinch L; Evensen SA; Blomhoff JP; Albrechtsen D
    Tidsskr Nor Laegeforen; 1993 Nov; 113(27):3351-3. PubMed ID: 8273060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Present status of donor leukocyte transfusion for leukemia. Relapse after allogeneic bone marrow transplantation in Japan].
    Morishima Y; Kodera Y
    Rinsho Ketsueki; 1997 Jun; 38(6):476-8. PubMed ID: 9248321
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1994 Jan; 13(1):5-10. PubMed ID: 8019452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
    Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
    Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.